CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT

Weller, Johannes and Zeyen, Thomas and Schlegel, Uwe and Lazaridis, Lazaros and Werner, Jan-Michael and Onken, Julia and Zeiner, Pia and Drexler, Richard and Hau, Peter and Seidel, Clemens and Grosse, Lucia and Clusmann, Hans and Sabel, Michael and Ringel, Florian and Pichler, Josef and Grauer, Oliver and Hundsberger, Thomas and Schnell, Oliver and Mair, Maximilian J. and Uhl, Martin and Schmidt-Graf, Friederike and Glas, Martin and Galldiks, Norbert and Unteroberdoerster, Meike and Steinbach, Joachim and Ricklefs, Franz and Renovanz, Mirjam and Delev, Daniel Ivanov and Turgut, Merih O. and Flesch, Oliver R. and Cipriani, Debora and Preusser, Matthias and Kebir, Sied and Misch, Martin and Goldbrunner, Roland and Westphal, Manfred and Tabatabai, Ghazaleh and Schaefer, Niklas and Schneider, Matthias and Vatter, Hartmut and Giordano, Frank and Schaub, Christina and Herrlinger, Ulrich (2022) CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT. In: 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 16-20, 2022, Tampa Bay, FL.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (UNSPECIFIED)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Neurologie
Depositing User:	Petra Gürster
Date Deposited:	21 Sep 2023 10:46
Last Modified:	21 Sep 2023 10:46
URI:	https://pred.uni-regensburg.de/id/eprint/58734

Actions (login required)

View Item